Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 4,950.00
-70.00 (-1.39%)
At close: Jun 19, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 44.71 billion as of June 18, 2026. Its market cap has decreased by -33.39% in one year.
Market Cap
44.71B
Enterprise Value
23.60B
Revenue
78.58B
Ranking
n/a
PE Ratio
151.07
Stock Price
4,950.00
Market Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 44.71B, a decrease of -35.90%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 44.71B | -22.20% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 237.21B |
| 3billion | 213.85B |
| GENINUS | 104.83B |
| Cytogen | 88.59B |
| Inventera | 82.90B |
| GC Medical Science | 74.68B |
| HLB Panagene | 70.48B |
| Protia | 53.45B |